Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Birt-Hogg-Dub(SqrRoot)(Copyright) Syndrome: Characterization of the FLCN Disease Gene and Predisposition to Renal Cancer, Cutaneous Fibrofolliculoma and Pulmonary Cysts

NCT00033137 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00033137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00033137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Birt-Hogg-Dub(SqrRoot)(Copyright) Syndrome: Characterization of the FLCN Disease Gene and Predisposition to Renal Cancer, Cutaneous Fibrofolliculoma and Pulmonary Cysts
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Recruiting
Start date
May 13, 2002
Completion date
Not reported
Enrollment
950 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

flcn protein, human, kidney cancer, kidney neoplasms, pneumothorax